Zoloft: Restore Emotional Balance with Effective SSRI Therapy
| Product dosage: 100mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.47 | $44.18 (0%) | 🛒 Add to cart |
| 60 | $0.99 | $88.36 $59.24 (33%) | 🛒 Add to cart |
| 90 | $0.83 | $132.54 $74.30 (44%) | 🛒 Add to cart |
| 120 | $0.76 | $176.72 $91.37 (48%) | 🛒 Add to cart |
| 180 | $0.67 | $265.08 $121.49 (54%) | 🛒 Add to cart |
| 270 | $0.62 | $397.61 $166.68 (58%) | 🛒 Add to cart |
| 360 | $0.60
Best per pill | $530.15 $214.87 (59%) | 🛒 Add to cart |
Zoloft (sertraline HCl) is a selective serotonin reuptake inhibitor (SSRI) approved by the FDA for the treatment of major depressive disorder (MDD), obsessive-compulsive disorder (OCD), panic disorder, post-traumatic stress disorder (PTSD), social anxiety disorder, and premenstrual dysphoric disorder (PMDD). As a cornerstone of modern psychopharmacology, it functions by increasing serotonin levels in the brain, a neurotransmitter critically involved in mood regulation. Its well-established efficacy, extensive clinical history, and generally favorable tolerability profile make it a first-line choice for many healthcare providers managing these conditions. This product card provides a comprehensive, evidence-based overview for medical professionals and informed patients.
Features
- Active Ingredient: Sertraline Hydrochloride
- Drug Class: Selective Serotonin Reuptake Inhibitor (SSRI)
- Available Formulations: Oral tablets (25 mg, 50 mg, 100 mg) and oral concentrate (20 mg/mL)
- Bioavailability: Approximately 80-90% following oral administration
- Time to Peak Plasma Concentration: 4.5 to 8.4 hours post-dose
- Half-Life: Sertraline exhibits a half-life of approximately 26 hours; its less active metabolite, N-desmethylsertraline, has a half-life of 62-104 hours
- Protein Binding: >98%
- Metabolism: Primarily hepatic, via CYP2B6, CYP2C9, CYP2C19, CYP2D6, and CYP3A4
- Excretion: Approximately 40-45% excreted in urine and 40-45% in feces over a 9-day period, primarily as metabolites
Benefits
- Effective Symptom Reduction: Clinically proven to significantly reduce the core symptoms of depression, including low mood, anhedonia, and fatigue, as measured by standardized rating scales like the HAM-D.
- Anxiety Management: Demonstrates robust efficacy in reducing the frequency and intensity of panic attacks, alleviating social anxiety, and mitigating symptoms of PTSD and OCD.
- Improved Functional Outcomes: By alleviating psychiatric symptoms, it can help restore occupational and social functioning, enhancing overall quality of life.
- Flexible Dosing: A range of available tablet strengths allows for precise, individualized titration to achieve optimal therapeutic effect while managing side effects.
- Established Safety Profile: With decades of post-marketing surveillance, its long-term safety and side effect profile are well-characterized within the medical community.
- Non-Sedating for Most Patients: Unlike some older antidepressants, it is generally not associated with significant daytime sedation, supporting daily activity.
Common use
Zoloft (sertraline) is indicated for the treatment of:
- Major Depressive Disorder (MDD): For the acute and maintenance treatment of MDD in adults. Efficacy in pediatric patients (ages 6-17) has also been established for this indication.
- Obsessive-Compulsive Disorder (OCD): For the acute and maintenance treatment of OCD in adults, adolescents, and children (ages 6 and above).
- Panic Disorder: For the acute and maintenance treatment of panic disorder, with or without agoraphobia, in adults.
- Post-Traumatic Stress Disorder (PTSD): For the acute treatment of PTSD in adults.
- Social Anxiety Disorder: For the acute and maintenance treatment of social anxiety disorder in adults.
- Premenstrual Dysphoric Disorder (PMDD): For the treatment of PMDD in adults.
It is important to note that the full antidepressant or anti-anxiety effect may not be realized for 4 to 6 weeks, and sometimes longer for OCD. Patients should be advised to continue therapy as directed even if they do not feel immediate improvement.
Dosage and direction
Administration: Zoloft is administered orally, once daily, either in the morning or evening. It can be taken with or without food; however, consistent administration with food may mitigate potential gastrointestinal upset. The oral concentrate must be diluted before use; mix the prescribed dose with 4 ounces (½ cup) of water, ginger ale, lemon/lime soda, lemonade, or orange juice ONLY. Do not mix with any other liquids.
Dosing by Indication (Adults):
- MDD and PTSD: Initial dose is 50 mg once daily. Dose may be increased in increments of 50 mg at intervals of no less than one week, based on clinical response and tolerability. The maximum recommended dose is 200 mg/day.
- OCD and Panic Disorder: Initial dose is 25 mg once daily. After one week, the dose should be increased to 50 mg once daily. This gradual start is intended to reduce the initial potential for anxiety and insomnia sometimes associated with initiation. Subsequent increases may be made in increments of 50 mg at weekly intervals. The effective dose range is typically 50-200 mg/day.
- Social Anxiety Disorder: Initial and recommended dose is 25 mg once daily. After one week, the dose should be increased to 50 mg once daily. Based on response, doses may be increased in 50 mg increments at weekly intervals up to a maximum of 200 mg/day.
- PMDD: The recommended initial dose is 50 mg per day, either daily throughout the menstrual cycle or limited to the luteal phase (the latter dosing regimen is recommended). Dose may be increased up to 150 mg/day per cycle for daily dosing, or up to 100 mg/day for luteal phase dosing.
Dosage adjustments are necessary in patients with hepatic impairment. Use in pediatric patients requires careful consideration and weight-based dosing; consult full prescribing information.
Precautions
- Suicidal Thoughts and Behaviors: Antidepressants increased the risk of suicidal thoughts and behavior in children, adolescents, and young adults (ages 18-24) in short-term studies. All patients starting therapy should be monitored closely for clinical worsening, suicidality, or unusual changes in behavior, especially during the initial few months of therapy and after dose changes. Families and caregivers should be advised of this need for close observation.
- Serotonin Syndrome: This potentially life-threatening condition may occur with Zoloft, particularly when used concomitantly with other serotonergic drugs. Symptoms include mental status changes, autonomic instability, neuromuscular aberrations, and gastrointestinal symptoms. If suspected, discontinue Zoloft and initiate supportive treatment.
- Activation of Mania/Hypomania: Screen patients for bipolar disorder prior to initiation. Treatment with an antidepressant may precipitate a manic or hypomanic episode. Use with caution in patients with a history of mania.
- Seizures: Use with caution in patients with a history of seizures. Discontinue in any patient who develops a seizure.
- Abnormal Bleeding: SSRIs and SNRIs may increase the risk of bleeding events. Concomitant use of aspirin, NSAIDs, warfarin, and other anticoagulants may add to this risk.
- Angle-Closure Glaucoma: The pupillary dilation that can occur with SSRIs may trigger an angle-closure attack in a patient with anatomically narrow angles who does not have a patent iridectomy.
- Hyponatremia: SSRI use can lead to syndrome of inappropriate antidiuretic hormone secretion (SIADH), resulting in hyponatremia. Elderly patients and those taking diuretics are at greater risk.
- Discontinuation Syndrome: Abrupt discontinuation should be avoided. A gradual dose reduction is recommended to minimize the risk of discontinuation symptoms (e.g., dizziness, nausea, headache, paresthesia, irritability).
Contraindications
Zoloft is contraindicated in patients:
- Taking, or within 14 days of stopping, monoamine oxidase inhibitors (MAOIs) due to the risk of serious, sometimes fatal, drug interactions, including serotonin syndrome.
- Taking pimozide (due to QT prolongation risk).
- Taking disulfiram (if using the oral concentrate formulation, which contains alcohol).
- With known hypersensitivity to sertraline or any excipient in the formulation.
Possible side effect
Very Common (≥1/10) and Common (≥1/100 to <1/10) side effects include:
- Gastrointestinal: Nausea, diarrhea, loose stools, dyspepsia, dry mouth, constipation
- Nervous System: Headache, dizziness, insomnia, somnolence, fatigue, tremor
- Psychiatric: Agitation, anxiety, decreased libido
- Other: Increased sweating, male sexual dysfunction (ejaculation failure, erectile dysfunction)
Uncommon, Rare, and Serious side effects require immediate medical attention and include:
- Suicidal ideation/behavior
- Serotonin syndrome
- Severe allergic reactions (rash, hives, swelling, difficulty breathing)
- Seizures
- Abnormal bleeding
- Mania/hypomania
- Hyponatremia
- Angle-closure glaucoma
- QT prolongation
Drug interaction
Zoloft is a moderate inhibitor of CYP2D6 and has a high potential for significant interactions:
- MAOIs: Absolute contraindication (see Contraindications).
- Pimozide: Contraindicated due to increased pimozide levels and risk of QT prolongation.
- Other Serotonergic Drugs: Use with extreme caution with other SSRIs, SNRIs, triptans, tramadol, tryptophan, lithium, and St. John’s Wort due to additive serotonergic effects and risk of serotonin syndrome.
- Drugs Metabolized by CYP2D6: Sertraline can increase plasma concentrations of drugs metabolized by this enzyme (e.g., tricyclic antidepressants, phenothiazines, some beta-blockers, some Type 1C antiarrhythmics like propafenone and flecainide). Dose adjustment of the co-administered drug may be necessary.
- Drugs that Prolong QT Interval: Use with caution with other drugs known to prolong the QT interval (e.g., certain antiarrhythmics, antipsychotics, antibiotics).
- Warfarin: May potentiate anticoagulant effect; closely monitor prothrombin time and INR.
- CNS Depressants: May potentiate the effects of alcohol, benzodiazepines, and other sedatives.
- NSAIDs/Aspirin: May increase risk of bleeding.
Missed dose
If a dose is missed, it should be taken as soon as remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped and the regular dosing schedule resumed. Do not double the dose to make up for a missed one.
Overdose
Overdose experience includes fatalities, primarily in mixed overdoses with other drugs and/or alcohol. Symptoms of overdose (alone) are largely extensions of common side effects and may include:
- Somnolence, nausea, vomiting, tachycardia, dizziness, agitation, tremor, dilated pupils, serotonin syndrome.
- Rarely, bradycardia, bundle branch block, coma, convulsions, delirium, hallucinations, hypertension, hypotension, manic reaction, pancreatitis, syncope, torsades de pointes, ventricular arrhythmia. There is no specific antidote. Management involves providing supportive care and addressing symptoms. Gastric lavage with airway protection may be indicated if performed soon after ingestion. Activated charcoal may be useful. Due to the large volume of distribution of sertraline, forced diuresis, dialysis, hemoperfusion, and exchange transfusion are unlikely to be of benefit.
Storage
- Store at room temperature, 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C to 30°C (59°F to 86°F).
- Keep the bottle tightly closed to protect from moisture and light.
- Keep out of reach of children and pets.
- The oral concentrate must be stored in the original bottle; after dilution, the prepared solution may be stored at room temperature but must be used within 24 hours.
Disclaimer
This information is for educational and informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or medication. Never disregard professional medical advice or delay in seeking it because of something you have read here. The author and publisher are not responsible for any specific health or allergy needs that may require medical supervision and are not liable for any damages or negative consequences from any treatment, action, application, or preparation, to any person reading or following the information in this product card.
Reviews
- “As a practicing psychiatrist for over 20 years, sertraline remains a first-line tool in my arsenal. Its predictable pharmacokinetics and generally manageable side effect profile allow for effective treatment in a wide range of anxiety and depressive disorders. The titration flexibility is key to patient adherence and success.” – Dr. A. Evans, MD
- “After struggling with panic disorder for years, starting Zoloft was a turning point. The first week was challenging with increased anxiety, but my doctor warned me this might happen. By the third week, the constant sense of dread began to lift. It’s not a ‘happy pill,’ but it gave me the stability to engage in therapy and rebuild my life.” – Patient M, 34
- “The extensive evidence base for sertraline across multiple indications provides a high degree of confidence in its use. Its favorable cost-effectiveness profile and availability as a generic make it accessible for a large patient population, which is a significant advantage in public health.” – Clinical Pharmacist Review
- “I prescribe it frequently for PMDD. The luteal-phase dosing option is particularly effective for many of my patients, minimizing overall medication exposure while effectively managing their debilitating cyclical symptoms.” – OB/GYN Practitioner